MYND Life Sciences Provides Update on Depression Gene Modulation Pathway Patent Application
Ryan Allway December 15th, 2021 Psychedelics VANCOUVER, BC, Dec. 15, 2021 /CNW/ – MYND Life Sciences Inc. (“MYND” or the “Company“) (CSE: MYND) (OTC: MYNDF) is pleased to announce it has completed the National Phase filing of its Patent Cooperation Treaty (PCT) patent application, following on previously submitted provisional patent applications that describe:... Read more
Rapid Dose Therapeutics Strengthens Leadership Team with Addition of Rodney Butt & Appoints New Advisory Board Member
Ryan Allway December 15th, 2021 Additions to support immediate commercialization efforts for the Company’s COVID-19 vaccine candidate BURLINGTON, Ontario, December 15, 2021–(BUSINESS WIRE)–Rapid Dose Therapeutics Corp. (“RDT” or the “Company“) (CSE: DOSE), a Canadian biotechnology company revolutionizing drug delivery through innovation, is pleased to announce a significant addition to... Read more
Allied Corp Partners with Trulife Distribution for the U.S. Health and Wellness Market
Ryan Allway December 15th, 2021 KELOWNA, British Columbia, Dec. 15, 2021 (GLOBE NEWSWIRE) — Allied Corp. (“Allied” or the “Company”) (OTCQB: ALID) is pleased to announce the signing of a non-exclusive national sales and distribution contract with Trulife Distribution. Under this agreement, TruLife agrees to distribute, market, and sell Allied’s... Read more
INDIVA SIGNS EXCLUSIVE LICENSING AND MANUFACTURING AGREEMENT WITH GRÖN
Ryan Allway December 15th, 2021 INDIVA TO BRING INNOVATIVE EDIBLES BRAND PORTFOLIO TO CANADA LONDON, ON, Dec. 15, 2021 /PRNewswire/ – Indiva Limited (the “Company” or “Indiva“) (TSXV: NDVA) (OTCQX: NDVAF), the leading Canadian producer of cannabis edibles, is pleased to announce that it has entered into a Licensing and Manufacturing Agreement with Oregon-based... Read more
Cybin Awarded Notice of Allowance from U.S. Patent and Trademark Office for CYB004 (Deuterated Psychedelic Tryptamine) for the Treatment of Anxiety Disorders
Ryan Allway December 15th, 2021 Psychedelics – Expands intellectual property portfolio and strengthens position as leading innovator in developing putative psychedelic compounds – TORONTO–(BUSINESS WIRE)– Cybin Inc. ( NEO:CYBN) ( NYSE American:CYBN) (“ Cybin” or the “ Company”), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics TM” today announced that it has been awarded a... Read more
A New York lawmaker on Monday introduced a bill to legalize psilocybin mushrooms for medical purposes and establish facilities where the psychedelic could be grown and administered to patients. Assemblyman Pat Burke (D) filed the legislation, which would create a system in New York that’s similar to the psilocybin... Read more
A New York lawmaker on Monday introduced a bill to legalize psilocybin mushrooms for medical purposes and establish facilities where the psychedelic could be grown and administered to patients. Assemblyman Pat Burke (D) filed the legislation, which would create a system in New York that’s similar to the psilocybin... Read more
A New York lawmaker on Monday introduced a bill to legalize psilocybin mushrooms for medical purposes and establish facilities where the psychedelic could be grown and administered to patients. Assemblyman Pat Burke (D) filed the legislation, which would create a system in New York that’s similar to the psilocybin... Read more
The Military Mental Health Crisis, A National Tragedy: Part I

The ongoing and worsening mental health crisis in the U.S. military is a national tragedy and a national disgrace. Part I reveals the ugly Big Picture.

Read more
MINDCURE (CSE: MCUR) (OTCQX: MCURF) Appoints Dr. Doron Sagman as Chief Medical Officer

Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) (FRA: 6MH) announces the appointment of Doron Sagman, MD, FRCPC, as the Company’s new Chief Medical Officer (“CMO”)

Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )